ABPI’s 6.88% Rebate Proposal ‘Completely Unaffordable,’ Says UK Health Dept

Plans for a new kind of drug pricing scheme put forward by the UK ABPI are intended to put the life sciences sector “back on the path for future growth,” the association says.